Palisade Bio (PALI)

• Market cap: $337M
• 1 day: 5.43%
• 5 days: 15.48%
• 1 month: -2.51%
• 3 months: 1.57%
• 6 months: -7.18%
• Year to date: -22.4%
• 1 year: 176.59%
• 5 years: -99.94%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Employees: 14